期刊文献+
共找到1篇文章
< 1 >
每页显示 20 50 100
Remote loading paclitaxel-doxorubicin prodrug into liposomes for cancer combination therapy 被引量:8
1
作者 Jiang Yu Yingli Wang +7 位作者 Shuang Zhou Jinbo Li Jiamei Wang dongxu chi Xue Wang Guimei Lin Zhonggui He Yongjun Wang 《Acta Pharmaceutica Sinica B》 SCIE CAS CSCD 2020年第9期1730-1740,共11页
The combination of paclitaxel(PTX)and doxorubicin(DOX)has been widely used in the clinic.However,it remains unsatisfied due to the generation of severe toxicity.Previously,we have successfully synthesized a prodrug PT... The combination of paclitaxel(PTX)and doxorubicin(DOX)has been widely used in the clinic.However,it remains unsatisfied due to the generation of severe toxicity.Previously,we have successfully synthesized a prodrug PTX-S-DOX(PSD).The prodrug displayed comparable in vitro cytotoxicity compared with the mixture of free PTX and DOX.Thus,we speculated that it could be promising to improve the anti-cancer effect and reduce adverse effects by improving the pharmacokinetics behavior of PSD and enhancing tumor accumulation.Due to the fact that copper ions(Cu2+)could coordinate with the anthracene nucleus of DOX,we speculate that the prodrug PSD could be actively loaded into liposomes by Cu2+gradient.Hence,we designed a remote loading liposomal formulation of PSD(PSD LPs)for combination chemotherapy.The prepared PSD LPs displayed extended blood circulation,improved tumor accumulation,and more significant anti-tumor efficacy compared with PSD NPs.Furthermore,PSD LPs exhibited reduced cardiotoxicity and kidney damage compared with the physical mixture of Taxol and Doxil,indicating better safety.Therefore,this novel nano-platform provides a strategy to deliver doxorubicin with other poorly soluble antineoplastic drugs for combination therapy with high efficacy and low toxicity. 展开更多
关键词 Combination therapy NANOPARTICLES Paclitaxel-doxorubicin prodrug Remote loading liposomes PRODRUG Safety
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部